Granulomatous Mastitis
14
2
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.4% vs benchmark
14%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (14)
Observation Alone for Mild Non-Lactational Mastitis
Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis
Validity and Reliability of the Mastitis Symptom Severity Assessment Methods (M-Score and BISSI) in Non-Lactational Mastitis
Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis
GRAnulomatous MAstitis REGistry Study
Could Intralesional Steroid be the Novel Treatment for Granulomatous Mastitis?
Effect of Different Surgical Approaches of Granulomatous Mastitis
Ductal Lavage Versus Corticosteroids Therapy for Idiopathic Granulomatous Mastitis
Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis
Immune Cells in Patients With Granulomatous Mastitis
Serum Cytokine Values in Patients With Granulomatous Mastitis
Local Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)
Medical and Surgical Treatment for Idiopathic Granulomatous Mastitis
Granulomatous Mastitis Current Approach and Treatment